What are the long-term effects I should watch for after Multiple Myeloma treatment

Long-Term Effects to Monitor After Multiple Myeloma Treatment

This is an important question, and it's great that you're thinking ahead about your health. According to the NCCN Guidelines for Multiple Myeloma, there are several long-term effects and complications you should be aware of and discuss with your care team.

Key Long-Term Concerns

1. Bone Health & Fracture Risk

Multiple myeloma damages bones, and this can persist even after treatment. According to NCCN Guidelines:

• Bone damage from myeloma may continue to be a concern long-term
• You may experience ongoing bone pain or increased fracture risk
• Bone-targeting treatments (bisphosphonates or denosumab) are typically continued for up to 2 years during treatment
• Important note: If you stop denosumab, your doctor may recommend maintenance denosumab every 6 months or a single bisphosphonate dose to prevent rebound bone loss

2. Kidney Function

Kidney problems are common in multiple myeloma and require ongoing monitoring:

• Myeloma can cause kidney damage from excess M proteins (abnormal antibodies) building up in your system
• Some treatments can also affect kidney function
• Regular blood and urine tests should continue to monitor kidney health
• According to NCCN Guidelines, renal dysfunction monitoring is essential throughout your care

3. Infection Risk

People with myeloma have a higher risk for infections that can persist:

• Myeloma reduces your body's ability to make normal, protective antibodies
• Some treatments can lower white blood cell counts
• You may need vaccinations and preventive medications
• Report any signs of infection (fever, unusual symptoms) promptly to your care team

4. Blood Clots (Venous Thromboembolism)

According to NCCN Guidelines:

• Multiple myeloma and certain treatments increase your risk for blood clots
• Your doctor may recommend blood thinners during and after treatment
• Watch for signs like leg swelling, chest pain, or shortness of breath

5. Secondary Cancers

This is an important long-term consideration:

• Some myeloma treatments (particularly lenalidomide used in maintenance therapy) slightly increase the risk of developing another cancer
• This is one reason your care team carefully weighs the benefits and risks of maintenance therapy with you
• Regular screening and monitoring become even more important

6. Heart & Organ Function

Certain treatments can affect heart health:

• Some myeloma drugs may impact heart function
• Your doctor may recommend an echocardiogram (heart ultrasound) if needed
• Ongoing monitoring of organ function is part of survivorship care

7. Anemia (Low Red Blood Cells)

• Myeloma can cause anemia that may persist after treatment
• You may experience fatigue or weakness
• Regular blood counts help monitor this

8. Neuropathy (Nerve Damage)

• Some myeloma treatments (particularly proteasome inhibitors like bortezomib) can cause numbness or tingling in hands and feet
• This may improve after treatment ends, but can sometimes be long-lasting
• Report any new or worsening nerve symptoms to your doctor

What Your Follow-Up Care Should Include

According to NCCN Guidelines, your follow-up should include:

Regular Testing:

• Complete blood count (CBC) with differential
• Blood chemistry tests
• Kidney function tests
• Serum and urine protein tests (to monitor for myeloma recurrence)
• Imaging (PET/CT, low-dose CT, or MRI) annually or as clinically indicated
• Bone marrow testing if relapse is suspected

Monitoring Schedule:

• Follow-up visits should occur regularly as recommended by your care team
• Testing frequency may decrease over time if you remain in remission

Important Reminders

Myeloma often returns, which is why ongoing monitoring is so important. According to NCCN Guidelines:

• Even with excellent treatment, multiple myeloma frequently comes back months or years after remission
• This is the nature of the disease, not a failure of treatment
• Early detection through regular monitoring allows for prompt treatment of relapse

Questions to Ask Your Care Team

To ensure you have a comprehensive survivorship plan, ask:

1. "What specific long-term side effects should I watch for based on MY treatment plan?" (Different drug combinations have different risks)

2. "How often should I have follow-up appointments and testing?"

3. "What symptoms should I report immediately, and who should I contact?"

4. "Do I need any preventive medications (like blood thinners or infection prophylaxis)?"

5. "Should I have bone density scans or other specific monitoring?"

6. "What's my risk for secondary cancer, and how should I be screened?"

7. "Are there lifestyle changes that can help reduce my long-term risks?"

8. "How long will I need bone-targeting treatment, and what happens if I stop?"

9. "Should I see any specialists (cardiologist, nephrologist) for ongoing monitoring?"

10. "What clinical trials might be available if my myeloma returns?"

Resources for More Information

The NCCN Guidelines for Patients: Multiple Myeloma (2025) provides detailed information about survivorship care and what to expect. You can also find information through:

• American Cancer Society
• National Cancer Institute (NCI)
• Leukemia & Lymphoma Society (excellent resource specifically for blood cancers)

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about your specific long-term care plan.